Drug: epirubicin Quarter: 2016Q3
Total Records: 477 Number of Pages: 24
DRUGNAME | PT | EventCount |
---|---|---|
EPIRUBICIN HCL | Febrile neutropenia | 3 |
EPIRUBICIN HCL | Gastroenteritis | 3 |
EPIRUBICIN HCL | Haemoglobin decreased | 3 |
EPIRUBICIN HCL | Pain in extremity | 3 |
EPIRUBICIN HCL | Peripheral swelling | 3 |
EPIRUBICIN HCL | Pyrexia | 3 |
EPIRUBICIN HYDROCHLORIDE. | Gastroenteritis | 3 |
EPIRUBICIN HYDROCHLORIDE. | Injection site mass | 3 |
epirubicine | Lung disorder | 3 |
EPIRUBICIN | Amenorrhoea | 2 |
Epirubicin | Cardiac failure | 2 |
Epirubicin | Cardiovascular disorder | 2 |
EPIRUBICIN | Deafness | 2 |
EPIRUBICIN | Ejection fraction decreased | 2 |
Epirubicin | Haemorrhage | 2 |
Epirubicin | Hypersensitivity | 2 |
EPIRUBICIN | Injection site reaction | 2 |
Epirubicin | Liver function test increased | 2 |
EPIRUBICIN | Major depression | 2 |
Epirubicin | Metastases to lymph nodes | 2 |
Total Records: 477 Number of Pages: 24